Pathogenesis of spinal cord injuries and mechanisms of repair induced by olfactory ensheathing cells;Patogenia de la lesión medular y mecanismos de reparación inducidos por las células de la glía envolvente olfatoria

Revista de Neurologia

Volumn 56, Issue 10, 2013, Pages 521-531

  Botero, Lucía ^b   Gómez, Rosa Margarita ^a   Chaparro, Orlando ^b  

^a UNIVERSIDAD DE LA SABANA   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Axonal regeneration; Cellular transplants; Neuronal regeneration; Olfactory ensheathing cells; Remielinization; Spinal cord injury

Indexed keywords

HUMAN; NERVE FIBER REGENERATION; OLFACTORY ENSHEATHING CELL; PATHOGENESIS; REMYELINIZATION; REVIEW; SCAR FORMATION; SPINAL CORD INJURY; SPINAL CORD REGENERATION; ANIMAL; ASTROCYTE; CELL TRANSPLANTATION; COMPLICATION; CYTOLOGY; DEMYELINATING DISEASES; EDEMA; ISCHEMIA; LYMPHOCYTE; MACROPHAGE; MICROCIRCULATION; MICROGLIA; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUTROPHIL; OLFACTORY BULB; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REGENERATION; RETROGRADE DEGENERATION; SCAR; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURIES; STEM CELL; VASCULARIZATION; WOUND HEALING; DEMYELINATING DISEASE;

CYTOKINE; NERVE GROWTH FACTOR; NERVE PROTEIN;

ANIMALS; ASTROCYTES; CELL TRANSPLANTATION; CICATRIX; CYTOKINES; DEMYELINATING DISEASES; EDEMA; HUMANS; ISCHEMIA; LYMPHOCYTES; MACROPHAGES; MICE; MICROCIRCULATION; MICROGLIA; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROGENESIS; NEUTROPHILS; OLFACTORY BULB; RATS; REGENERATION; RETROGRADE DEGENERATION; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURIES; STEM CELLS; WOUND HEALING;

EID: 84878435596     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5610.2013109     Document Type: Review

References (146)

1. DeVivo MJ, Chen Y. Trends in new injuries, prevalent cases, and aging with spinal cord injury. Arch Phys Med Rehabil 2011; 92: 332-8.
2. Shingu H, Ohama M, Ikata T, Katoh S, Akatsu T. A nationwide epidemiological survey of spinal cord injuries in Japan from January 1990 to December 1992. Paraplegia 1995; 33: 183-8.
3. DeVivo MJ, Fine PR, Maetz HM, Stover SL. Prevalence of spinal cord injury: a reestimation employing life table techniques. Arch Neurol 1980; 37: 707-8.
4. Harvey C, Rothschild BB, Asmann AJ, Stripling T. New estimates of traumatic SCI prevalence: a survey-based approach. Paraplegia 1990; 28: 537-44.
5. Taoka Y, Okajima K. Spinal cord injury in the rat. Prog Neurobiol 1998; 56: 341-58.
6. Cheng H, Cao Y, Olson L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 1996; 273: 510-3.
7. Oudega M, Xu XM. Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma 2006; 23: 453-67.
8. Andrews MR, Stelzner DJ. Evaluation of olfactory ensheathing and Schwann cells after implantation into a dorsal injury of adult rat spinal cord. J Neurotrauma 2007; 24: 1773-92.
9. Guo JS, Zeng YS, Li HB, Huang WL, Liu RY, Li XB, et al. Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord 2007; 45: 15-24.
10. Ramon-Cueto A, Nieto-Sampedro M. Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp Neurol 1994; 127: 232-44.
11. Li Y, Field PM, Raisman G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 1997; 277: 2000-2.
12. Imaizumi T, Lankford KL, Waxman SG, Greer CA, Kocsis JD. Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci 1998; 18: 6176-85.
13. Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 2000; 25: 425-35.
14. Tator CH. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 1998; 42: 696-708.
15. Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999; 44: 1027-40.
16. McDonald JW, Sadowsky C. Spinal-cord injury. Lancet 2002; 359: 417-25.
17. Anthes DL, Teriault E, Tator CH. Ultrastructural evidence for arteriolar vasospasm after spinal cord trauma. Neurosurgery 1996; 39: 804-14.
18. Griffths IR, Burns N, Crawford AR. Early vascular changes in the spinal grey matter following impact injury. Acta Neuropathol 1978; 41: 33-9.
19. Sharma HS. Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr Pharm Des 2005; 11: 1353-89.
20. Sharma HS. New perspectives for the treatment options in spinal cord injury. Expert Opin Pharmacother 2008; 9: 2773-800.
21. Sharma HS. A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury. Ann N Y Acad Sci 2007; 1122: 95-111.
22. Balentine JD. Spinal cord trauma: in search of the meaning of granular axoplasm and vesicular myelin. J Neuropathol Exp Neurol 1988; 47: 77-92.
23. Anthes DL, Teriault E, Tator CH. Characterization of axonal ultrastructural pathology following experimental spinal cord compression injury. Brain Res 1995; 702: 1-16.
24. Nieto-Sampedro M, Collazos-Castro JE, Taylor JS, Gudino-Cabrera G, Verdí-Navarro E, Pascual-Piedrola JI, et al. Trauma en el sistema nervioso central y su reparación. Rev Neurol 2002; 35: 534-52.
25. Rodríguez AV. Lesión de la médula espinal: mecanismos del daño medular. Boletín del Departamento de Docencia e Investigación IREP 2004; 4: 69-73.
26. Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 1991; 37: 291-302.
27. Guha A, Tator CH, Rochon J. Spinal cord blood fow and systemic blood pressure after experimental spinal cord injury in rats. Stroke 1989; 20: 372-7.
28. Koyanagi I, Tator CH, Lea PJ. Tree-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts. Part 1: normal spinal cord. Neurosurgery 1993; 33: 277-84.
29. Conti A, Miscusi M, Cardali S, Germano A, Suzuki H, Cuzzocrea S, et al. Nitric oxide in the injured spinal cord: syntheses cross-talk, oxidative stress and infammation. Brain Res Rev 2007; 54: 205-18.
30. Sinescu C, Popa F, Grigorean VT, Onose G, Sandu AM, Popescu M, et al. Molecular basis of vascular events following spinal cord injury. J Med Life 2010; 3: 254-61.
31. Bell MT, Puskas F, Smith PD, Agoston VA, Fullerton DA, Meng X, et al. Attenuation of spinal cord ischemia-reperfusion injury by specifc alpha-2a receptor activation with dexmedetomidine. J Vasc Surg 2012; 56: 1398-402.
32. Tator CH, Koyanagi I. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 1997; 86: 483-92.
33. Zhu DJ, Xia B, Bi Q, Zhang SJ, Qiu BS, Zhao C. Functional protection of pentoxifylline against spinal cord ischemia/ reperfusion injury in rabbits: necrosis and apoptosis effects. Chin Med J (Engl) 2008; 121: 2444-9.
34. Bao F, Bailey CS, Gurr KR, Bailey SI, Rosas-Arellano MP, Dekaban GA, et al. Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Exp Neurol 2009; 215: 308-16.
35. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, et al. The cellular inflammatory response in human spinal cords after injury. Brain 2006; 129: 3249-69.
36. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience 1997; 79: 1177-82.
37. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010; 133: 433-47.
38. Nguyen HX, Beck KD, Anderson AJ. Quantitative assessment of immune cells in the injured spinal cord tissue by fow cytometry: a novel use for a cell purifcation method. J Vis Exp 2011; Apr 9. [Epub ahead of print].
39. Pineau I, Sun L, Bastien D, Lacroix S. Astrocytes initiate infammation in the injured mouse spinal cord by promoting the entry of neutrophils and infammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav Immun 2010; 24: 540-53.
40. Popovich PG, Guan Z, McGaughy V, Fisher L, Hickey WF, Basso DM. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol 2002; 61: 623-33.
41. Nguyen HX, Galvan MD, Anderson AJ. Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury. J Neuroinfammation 2008; 5: 26.
42. Popovich PG, Hickey WF. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 2001; 60: 676-85.
43. Pineau I, Lacroix S. Proinfammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007; 500: 267-85.
44. Probert L, Eugster H P, Akassoglou K, Bauer J, Frei K, Lassmann H, et al. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 2000; 123: 2005-19.
45. David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 2011; 12: 388-99.
46. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting J P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 2001; 4: 1116-22.
47. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201: 647-57.
48. Bouhy D, Malgrange B, Multon S, Poirrier AL, Scholtes F, Schoenen J, et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J 2006; 20: 1239-41.
49. Martínez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-83.
50. Schwartz Y, Svistelnik AV. Functional phenotypes of macrophages and the m1-m2 polarization concept. Part I. Proinfammatory phenotype. Biochemistry (Mosc) 2012; 77: 246-60.
51. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-44.
52. Ankeny DP, Guan Z, Popovich PG. B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest 2009; 119: 2990-9.
53. Ankeny DP, Popovich PG. B cells and autoantibodies: complex roles in CNS injury. Trends Immunol 2010; 31: 332-8.
54. Wu B, Matic D, Djogo N, Szpotowicz E, Schachner M, Jakovcevski I. Improved regeneration after spinal cord injury in mice lacking functional T-and B-lymphocytes. Exp Neurol 2012; 237: 274-85.
55. Rice T, Larsen J, Rivest S, Yong VW. Characterization of the early neuroinfammation after spinal cord injury in mice. J Neuropathol Exp Neurol 2007; 66: 184-95.
56. Sato A, Ohtaki H, Tsumuraya T, Song D, Ohara K, Asano M, et al. Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury. J Neuroinfammation 2012; 9: 65.
57. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C, Esposito E, et al. TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 2008; 29: 32-41.
58. Chen KB, Uchida K, Nakajima H, Yayama T, Hirai T, Watanabe S, et al. Tumor necrosis factor-alpha antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila Pa 1976) 2011; 36: 1350-8.
59. Inukai T, Uchida K, Nakajima H, Yayama T, Kobayashi S, Mwaka ES, et al. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression. Spine (Phila Pa 1976) 2009; 34: 2848-57.
60. Mukaino M, Nakamura M, Yamada O, Okada S, Morikawa S, Renault-Mihara F, et al. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 2010; 224: 403-14.
61. Guerrero AR, Uchida K, Nakajima H, Watanabe S, Nakamura M, Johnson WE, et al. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinfammation 2012; 9: 40.
62. Cho N, Nguyen DH, Satkunendrarajah K, Branch DR, Fehlings MG. Evaluating the role of IL-11, a novel cytokine in the IL-6 family, in a mouse model of spinal cord injury. J Neuroinflammation 2012; 9: 134.
63. Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 2002; 115: 839-49.
64. Bao F, Chen Y, Dekaban GA, Weaver LC. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 2004; 88: 1335-44.
65. Sun D, Lye-Barthel M, Masland RH, Jakobs TC. Structural remodeling of fbrous astrocytes after axonal injury. J Neurosci 2010; 30: 14008-19.
66. Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR, et al. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci 2011; 31: 6053-8.
67. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, et al. Inhibition of astroglial nuclear factor kappaB reduces infammation and improves functional recovery after spinal cord injury. J Exp Med 2005; 202: 145-56.
68. Fitch MT, Silver J. CNS injury, glial scars, and infammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008; 209: 294-301.
69. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009; 32: 638-47.
70. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010; 119: 7-35.
71. Cao Z, Gao Y, Deng K, Williams G, Doherty P, Walsh FS. Receptors for myelin inhibitors: structures and therapeutic opportunities. Mol Cell Neurosci 2010; 43: 1-14.
72. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 2002; 22: 2792-803.
73. Akbik F, Cafferty WB, Strittmatter SM. Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol 2012; 235: 43-52.
74. Ji B, Case LC, Liu K, Shao Z, Lee X, Yang Z, et al. Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injury. Mol Cell Neurosci 2008; 39: 258-67.
75. Strittmatter S. Spinal cord regeneration: ready, set, nogo. Eukaryon 2010; 6: 55-60.
76. Filbin MT. Recapitulate development to promote axonal regeneration: good or bad approach? Philos Trans R Soc Lond B Biol Sci 2006; 361: 1565-74.
77. De Castro F. Wiring olfaction: the cellular and molecular mechanisms that guide the development of synaptic connections from the nose to the cortex. Front Neurosci 2009; 3: 52.
78. De Winter F, Oudega M, Lankhorst AJ, Hamers FP, Blits B, Ruitenberg MJ, et al. Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol 2002; 175: 61-75.
79. Lee JK, Chow R, Xie F, Chow SY, Tolentino KE, Zheng B. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insuficient to promote serotonergic axon regeneration. J Neurosci 2010; 30: 10899-904.
80. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 2003; 72: 609-42.
81. Radtke C, Wewetzer K. Translating basic research into clinical practice or what else do we have to learn about olfactory ensheathing cells? Neurosci Lett 2009; 456: 133-6.
82. Franssen EH, De Bree FM, Verhaagen J. Olfactory ensheathing glia: their contribution to primary olfactory nervous system regeneration and their regenerative potential following transplantation into the injured spinal cord. Brain Res Rev 2007; 56: 236-58.
83. Katoh H, Shibata S, Fukuda K, Sato M, Satoh E, Nagoshi N, et al. Te dual origin of the peripheral olfactory system: placode and neural crest. Mol Brain 2011; 4: 34.
84. Forni PE, Taylor-Burds C, Melvin VS, Williams T, Wray S. Neural crest and ectodermal cells intermix in the nasal placode to give rise to GnRH-1 neurons, sensory neurons, and olfactory ensheathing cells. J Neurosci 2011; 31: 6915-27.
85. Ramón-Cueto A, Ávila J. Olfactory ensheathing glia: properties and function. Brain Res Bull 1998; 46: 175-87.
86. Sasaki M, Lankford KL, Zemedkun M, Kocsis JD. Identifed olfactory ensheathing cells transplanted into the transected dorsal funiculus bridge the lesion and form myelin. J Neurosci 2004; 24: 8485-93.
87. Au E, Roskams AJ. Olfactory ensheathing cells of the lamina propria in vivo and in vitro. Glia 2003; 41: 224-36.
88. Su Z, He C. Olfactory ensheathing cells: biology in neural development and regeneration. Prog Neurobiol 2010; 92: 517-32.
89. Richter MW, Fletcher PA, Liu J, Tetzlaff W, Roskams AJ. Lamina propria and olfactory bulb ensheathing cells exhibit differential integration and migration and promote differential axon sprouting in the lesioned spinal cord. J Neurosci 2005; 25: 10700-11.
90. Bauer S, Rasika S, Han J, Mauduit C, Raccurt M, Morel G, et al. Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium. J Neurosci 2003; 23: 1792-803.
91. Hsu P, Yu F, Feron F, Pickles JO, Sneesby K, Mackay-Sim A. Basic fibroblast growth factor and fibroblast growth factor receptors in adult olfactory epithelium. Brain Res 2001; 896: 188-97.
92. Wu JC, Huang WC, Chen YC, Tu TH, Tsai YA, Huang SF, et al. Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial. J Neurosurg Spine 2011; 15: 216-27.
93. McCurdy RD, Feron F, McGrath JJ, Mackay-Sim A. Regulation of adult olfactory neurogenesis by insulin-like growth factor-I. Eur J Neurosci 2005; 22: 1581-8.
94. Chuah MI, Teague R. Basic fibroblast growth factor in the primary olfactory pathway: mitogenic effect on ensheathing cells. Neuroscience 1999; 88: 1043-50.
95. Bregman BS, McAtee M, Dai HN, Kuhn PL. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol 1997; 148: 475-94.
96. Bregman BS, Coumans JV, Dai HN, Kuhn PL, Lynskey J, McAtee M, et al. Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog Brain Res 2002; 137: 257-73.
97. Tsai MC, Shen LF, Kuo HS, Cheng H, Chak KF. Involvement of acidic fbroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach. Mol Cell Proteomics 2008; 7: 1668-87.
98. Bondy CA, Cheng CM. Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004; 490: 25-31.
99. Woodhall E, West AK, Chuah MI. Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res Mol Brain Res 2001; 88: 203-13.
100. Lipson AC, Widenfalk J, Lindqvist E, Ebendal T, Olson L. Neurotrophic properties of olfactory ensheathing glia. Exp Neurol 2003; 180: 167-71.
101. Roskams AJ, Bethel MA, Hurt KJ, Ronnett GV. Sequential expression of Trks A, B, and C in the regenerating olfactory neuroepithelium. J Neurosci 1996; 16: 1294-307.
102. Boruch AV, Conners JJ, Pipitone M, Deadwyler G, Storer PD, Devries GH, et al. Neurotrophic and migratory properties of an olfactory ensheathing cell line. Glia 2001; 33: 225-9.
103. Grill RJ, Blesch A, Tuszynski MH. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol 1997; 148: 444-52.
104. Jin Y, Fischer I, Tessler A, Houle JD. Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp Neurol 2002; 177: 265-75.
105. Tobias CA, Shumsky JS, Shibata M, Tuszynski MH, Fischer I, Tessler A, et al. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp Neurol 2003; 184: 97-113.
106. Lu KW, Chen ZY, Jin DD, Hou TS, Cao L, Fu Q. Cationic liposome-mediated GDNF gene transfer after spinal cord injury. J Neurotrauma 2002; 19: 1081-90.
107. Doucette R. Immunohistochemical localization of laminin, fibronectin and collagen type IV in the nerve fiber layer of the olfactory bulb. Int J Dev Neurosci 1996; 14: 945-59.
108. Gong Q, Shipley MT. Expression of extracellular matrix molecules and cell surface molecules in the olfactory nerve pathway during early development. J Comp Neurol 1996; 366: 1-14.
109. Liesi P. Laminin-immunoreactive glia distinguish regenerative adult CNS systems from non-regenerative ones. EMBO J 1985; 4: 2505-11.
110. Soussi-Yanicostas N, De Castro F, Julliard AK, Perfettini I, Chedotal A, Petit C. Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 2002; 109: 217-28.
111. Okano H, Sawamoto K. Neural stem cells: involvement in adult neurogenesis and CNS repair. Philos Trans R Soc Lond B Biol Sci 2008; 363: 2111-22.
112. Temple S, Álvarez-Buylla A. Stem cells in the adult mammalian central nervous system. Curr Opin Neurobiol 1999; 9: 135-41.
113. Okano H. Neural stem cells and strategies for the regeneration of the central nervous system. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 438-50.
114. Decimo I, Bifari F, Rodriguez FJ, Malpeli G, Dolci S, Lavarini V, et al. Nestin-and doublecortin-positive cells reside in adult spinal cord meninges and participate in injury-induced parenchymal reaction. Stem Cells 2011; 29: 2062-76.
115. Yamamoto S, Yamamoto N, Kitamura T, Nakamura K, Nakafuku M. Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord. Exp Neurol 2001; 172: 115-27.
116. Xu Y, Kitada M, Yamaguchi M, Dezawa M, Ide C. Increase in bFGF-responsive neural progenitor population following contusion injury of the adult rodent spinal cord. Neurosci Lett 2006; 397: 174-9.
117. Cao L, Mu L, Qiu Y, Su Z, Zhu Y, Gao L, et al. Diffusible, membrane-bound, and extracellular matrix factors from olfactory ensheathing cells have different effects on the self-renewing and differentiating properties of neural stem cells. Brain Res 2010; 1359: 56-66.
118. Silva NA, Cooke MJ, Tam RY, Sousa N, Salgado AJ, Reis RL, et al. Te effects of peptide modified gellan gum and olfactory ensheathing glia cells on neural stem/progenitor cell fate. Biomaterials 2012; 33: 6345-54.
119. Chehrehasa F, Ekberg JA, Lineburg K, Amaya D, Mackay-Sim A, St John JA. Two phases of replacement replenish the olfactory ensheathing cell population after injury in postnatal mice. Glia 2012; 60: 322-32.
120. Gorrie CA, Hayward I, Cameron N, Kailainathan G, Nandapalan N, Sutharsan R, et al. Efects of human OEC-derived cell transplants in rodent spinal cord contusion injury. Brain Res 2010; 1337: 8-20.
121. Li BC, Li Y, Chen LF, Chang JY, Duan ZX. Olfactory ensheathing cells can reduce the tissue loss but not the cavity formation in contused spinal cord of rats. J Neurol Sci 2011; 303: 67-74.
122. Sandvig I, Tuen M, Hoang L, Olsen O, Sardella TC, Brekken C, et al. In vivo MRI of olfactory ensheathing cell grafts and regenerating axons in transplant mediated repair of the adult rat optic nerve. NMR Biomed 2012; 25: 620-31.
123. Imaizumi T, Lankford KL, Kocsis JD. Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res 2000; 854: 70-8.
124. Radtke C, Akiyama Y, Brokaw J, Lankford KL, Wewetzer K, Fodor WL, et al. Remyelination of the nonhuman primate spinal cord by transplantation of H-transferase transgenic adult pig olfactory ensheathing cells. FASEB J 2004; 18: 335-7.
125. Sasaki M, Lankford KL, Radtke C, Honmou O, Kocsis JD. Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments. Exp Neurol 2011; 229: 88-98.
126. Deumens R, Koopmans GC, Joosten EA. Regeneration of descending axon tracts after spinal cord injury. Prog Neurobiol 2005; 77: 57-89.
127. Chung RS, Woodhouse A, Fung S, Dickson TC, West AK, Vickers JC, et al. Olfactory ensheathing cells promote neurite sprouting of injured axons in vitro by direct cellular contact and secretion of soluble factors. Cell Mol Life Sci 2004; 61: 1238-45.
128. Pellitteri R, Spatuzza M, Russo A, Zaccheo D, Stanzani S. Olfactory ensheathing cells represent an optimal substrate for hippocampal neurons: an in vitro study. Int J Dev Neurosci 2009; 27: 453-8.
129. Streppel M, Azzolin N, Dohm S, Guntinas-Lichius O, Haas C, Grothe C, et al. Focal application of neutralizing antibodies to soluble neurotrophic factors reduces collateral axonal branching after peripheral nerve lesion. Eur J Neurosci 2002; 15: 1327-42.
130. Au E, Richter MW, Vincent AJ, Tetzlaff W, Aebersold R, Sage EH, et al. SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair. J Neurosci 2007; 27: 7208-21.
131. Chuah MI, Choi-Lundberg D, Weston S, Vincent AJ, Chung RS, Vickers JC, et al. Olfactory ensheathing cells promote collateral axonal branching in the injured adult rat spinal cord. Exp Neurol 2004; 185: 15-25.
132. Verdu E, Garcia-Alias G, Fores J, Gudino-Cabrera G, Muneton VC, Nieto-Sampedro M, et al. Effects of ensheathing cells transplanted into photochemically damaged spinal cord. Neuroreport 2001; 12: 2303-9.
133. O'Toole DA, West AK, Chuah MI. Effect of olfactory ensheathing cells on reactive astrocytes in vitro. Cell Mol Life Sci 2007; 64: 1303-9.
134. Li Y, Li D, Raisman G. Interaction of olfactory ensheathing cells with astrocytes may be the key to repair of tract injuries in the spinal cord: the 'pathway hypothesis'. J Neurocytol 2005; 34: 343-51.
135. Li Y, Bao J, Khatibi NH, Chen L, Wang H, Duan Y, et al. Olfactory ensheathing cell transplantation into spinal cord prolongs the survival of mutant SOD1(G93A) ALS rats through neuroprotection and remyelination. Anat Rec (Hoboken) 2011; 294: 847-57.
136. Boyd JG, Doucette R, Kawaja MD. Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord. FASEB J 2005; 19: 694-703.
137. Masgutova GA, Savchenko EA, Viktorov I V, Masgutov RF, Chelyshev YA. Reaction of oligoglia to spinal cord injury in rats and transplantation of human olfactory ensheathing cells. Bull Exp Biol Med 2010; 149: 135-9.
138. Devon R, Doucette R. Olfactory ensheathing cells myelinate dorsal root ganglion neurites. Brain Res 1992; 589: 175-9.
139. Devon R, Doucette R. Olfactory ensheathing cells do not require L-ascorbic acid in vitro to assemble a basal lamina or to myelinate dorsal root ganglion neurites. Brain Res 1995; 688: 223-9.
140. Radtke C, Sasaki M, Lankford KL, Gallo V, Kocsis JD. CNPase expression in olfactory ensheathing cells. J Biomed Biotechnol 2011; 2011: 608496.
141. Akiyama Y, Lankford K, Radtke C, Greer CA, Kocsis JD. Remyelination of spinal cord axons by olfactory ensheathing cells and Schwann cells derived from a transgenic rat expressing alkaline phosphatase marker gene. Neuron Glia Biol 2004; 1: 47-55.
142. Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, Bunge MB. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci 2002; 22: 6670-81.
143. Riddell JS, Enriquez-Denton M, Toft A, Fairless R, Barnett SC. Olfactory ensheathing cell grafts have minimal influence on regeneration at the dorsal root entry zone following rhizotomy. Glia 2004; 47: 150-67.
144. McTigue DM, Tripathi RB. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 2008; 107: 1-19.
145. Yoo S, Wrathall JR. Mixed primary culture and clonal analysis provide evidence that NG2 proteoglycan-expressing cells after spinal cord injury are glial progenitors. Dev Neurobiol 2007; 67: 860-74.
146. Jiang S, Ballerini P, Buccella S, Giuliani P, Jiang C, Huang X, et al. Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine. Purinergic Signal 2008; 4: 61-71.